Cytek Biosciences
CTKB
CTKB
152 hedge funds and large institutions have $501M invested in Cytek Biosciences in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.98% more ownership
Funds ownership: 57% → 59.98% (+3%)
Holders
152
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$4.2M | |
| 2 | +$3.98M | |
| 3 | +$2.53M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.27M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.23M |
Top Sellers
| 1 | -$8.09M | |
| 2 | -$3.18M | |
| 3 | -$3.18M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.01M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$729K |